Published in Cardiovasc Ther on October 05, 2011
Impact of stress-induced diabetes on outcomes in severely burned children. J Am Coll Surg (2014) 1.53
The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol (2012) 1.31
Interaction of the endocrine system with inflammation: a function of energy and volume regulation. Arthritis Res Ther (2014) 0.85
Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. J Am Coll Cardiol (2008) 3.43
State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem (2012) 2.87
Allocation concealment and blinding: when ignorance is bliss. Med J Aust (2005) 2.85
Fibromyalgia syndrome: classification, diagnosis, and treatment. Dtsch Arztebl Int (2009) 2.85
Non-specific, functional, and somatoform bodily complaints. Dtsch Arztebl Int (2012) 2.85
Determining the sample size in a clinical trial. Med J Aust (2002) 2.51
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J (2006) 2.12
Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aust (2003) 2.06
Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D. Clin Chem Lab Med (2014) 2.01
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial. Lancet (2009) 1.88
Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA (2012) 1.71
Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J (2005) 1.66
Methyl donor deficiency induces cardiomyopathy through altered methylation/acetylation of PGC-1α by PRMT1 and SIRT1. J Pathol (2011) 1.61
Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp Hematol (2007) 1.55
Clinical significance of increased cardiac troponins T and I in participants of ultra-endurance events. Am J Cardiol (2004) 1.47
Statistical methods in clinical trials. Med J Aust (2003) 1.47
Subgroup analysis in clinical trials. Med J Aust (2004) 1.42
Putting results of a clinical trial into perspective. Med J Aust (2007) 1.42
Randomisation in clinical trials. Med J Aust (2002) 1.40
Age-related bone loss: old bone, new facts. Gerontology (2002) 1.38
Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus. J Am Coll Cardiol (2008) 1.26
Specifying objectives and outcomes for clinical trials. Med J Aust (2002) 1.24
Prevention and health promotion in undergraduate medical education: Preferences, attitudes and previous knowledge of medical students - a cross-sectional study. GMS Z Med Ausbild (2011) 1.18
Can self-rated health scores be used for risk prediction in patients with type 2 diabetes? Diabetes Care (2008) 1.18
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur Heart J (2009) 1.17
Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes. Med Care (2009) 1.12
Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis (2013) 1.09
Cost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial. Med J Aust (2005) 1.08
Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro. J Cell Mol Med (2009) 1.08
Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models. Diabetes (2012) 1.08
Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: the FIELD Study. Diabetes Care (2011) 1.08
Effect of lamin A/C knockdown on osteoblast differentiation and function. J Bone Miner Res (2009) 1.07
Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med (2005) 1.04
Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline. Ger Med Sci (2008) 1.03
Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk. Mol Aspects Med (2005) 1.03
Aging and bone loss: new insights for the clinician. Ther Adv Musculoskelet Dis (2012) 1.02
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial. Cardiovasc Diabetol (2011) 1.02
Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide in endurance athletes. Eur J Cardiovasc Prev Rehabil (2006) 0.99
Decreased bone formation and osteopenia in lamin a/c-deficient mice. PLoS One (2011) 0.99
Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL/6J mice. Biogerontology (2009) 0.98
Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism. Bone (2011) 0.96
Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort. Diabetes Care (2012) 0.95
Baseline data in clinical trials. Med J Aust (2003) 0.95
Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab (2007) 0.92
An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes. Diabetes (2013) 0.90
Accelerated features of age-related bone loss in zmpste24 metalloproteinase-deficient mice. J Gerontol A Biol Sci Med Sci (2009) 0.90
Age-related changes in lamin A/C expression in cardiomyocytes. Am J Physiol Heart Circ Physiol (2007) 0.89
Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational study. J Neurol Neurosurg Psychiatry (2012) 0.89
Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study. J Am Heart Assoc (2013) 0.89
Fat and bone interactions. Curr Osteoporos Rep (2014) 0.89
Multiple analyses in clinical trials: sound science or data dredging? Med J Aust (2004) 0.89
The measurement of 25-hydroxy vitamin D - an analytical challenge. Clin Chem Lab Med (2012) 0.88
Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling. Clin Chem Lab Med (2007) 0.87
Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate. Arterioscler Thromb Vasc Biol (2009) 0.87
Mechanisms of palmitate-induced lipotoxicity in human osteoblasts. Endocrinology (2013) 0.87
Is collectionism a diagnostic clue for Diogenes syndrome? Int J Geriatr Psychiatry (2005) 0.86
Health care for older persons in Colombia: a country profile. J Am Geriatr Soc (2009) 0.86
Generalising the results of trials to clinical practice. Med J Aust (2004) 0.86
Once-yearly zoledronic acid in hip fracture prevention. Clin Interv Aging (2009) 0.86
Mechanisms of palmitate-induced cell death in human osteoblasts. Biol Open (2013) 0.85
The orthogeriatrics model of care: systematic review of predictors of institutionalization and mortality in post-hip fracture patients and evidence for interventions. J Am Med Dir Assoc (2012) 0.85
Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes. J Clin Endocrinol Metab (2012) 0.85
Seasonal variance in serum levels of vitamin d determines a compensatory response by parathyroid hormone: study in an ambulatory elderly population in Quebec. Gerontology (2006) 0.85
Gait disorders are associated with non-cardiovascular falls in elderly people: a preliminary study. BMC Geriatr (2005) 0.85
Supplementation with vitamin D and calcium in long-term care residents. J Am Med Dir Assoc (2010) 0.85
Severe bone changes in a case of Hutchinson-Gilford syndrome. Ann Genet (2002) 0.85
Differential expression of cytokines in subcutaneous and marrow fat of aging C57BL/6J mice. Exp Gerontol (2009) 0.84
Determination of vitamin D and its metabolites. Best Pract Res Clin Endocrinol Metab (2013) 0.84
Sustained telomere erosion due to increased stem cell turnover during triple autologous hematopoietic stem cell transplantation. Exp Hematol (2007) 0.84
Alendronate affects calcium dynamics in cardiomyocytes in vitro. Vascul Pharmacol (2009) 0.83
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia (2014) 0.83
Assessment of vitamin D status - a changing landscape. Clin Chem Lab Med (2017) 0.82
Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Am Heart J (2012) 0.82
Validation of noninvasive quantification of bone marrow fat volume with microCT in aging rats. Exp Gerontol (2011) 0.82
Balloon warming time is the strongest predictor of late pulmonary vein electrical reconnection following cryoballoon ablation for atrial fibrillation. Heart Rhythm (2013) 0.82
The kynurenine pathway of tryptophan degradation is activated during osteoblastogenesis. Stem Cells (2015) 0.82
Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review. Clin Chem Lab Med (2007) 0.82
N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease. Clin Res Cardiol (2007) 0.82
25-Hydroxyvitamin D testing: challenging the performance of current automated immunoassays. Clin Chem Lab Med (2012) 0.82
Lamin A/C deficiency is associated with fat infiltration of muscle and bone. Mech Ageing Dev (2011) 0.82
Weight loss on stimulant medication: how does it affect body composition and bone metabolism? - A prospective longitudinal study. Int J Pediatr Endocrinol (2012) 0.81
Exercise for falls and fracture prevention in long term care facilities: a systematic review and meta-analysis. J Am Med Dir Assoc (2013) 0.80
Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status. Clin Chem Lab Med (2005) 0.80
Red cell or serum folate: what to do in clinical practice? Clin Chem Lab Med (2013) 0.80
Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans. Am J Clin Nutr (2009) 0.80
An evidence based clinical aid for cardiovascular disease--what do GPs think? Aust Fam Physician (2005) 0.79
High bone concentrations of homocysteine are associated with altered bone morphology in humans. Br J Nutr (2011) 0.79
Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study. Clin Chem Lab Med (2012) 0.79
Interferon gamma inhibits adipogenesis in vitro and prevents marrow fat infiltration in oophorectomized mice. Stem Cells (2012) 0.79
Folate is related to phosphorylated neurofilament-H and P-tau (Ser396) in rat brain. J Neurochem (2011) 0.79
The measurement of complexed prostate-specific antigen has a better performance than total prostate-specific antigen. Clin Chem Lab Med (2004) 0.78
Re: "Elevated serum homocysteine and McKusick's hypothesis of a disturbed collagen cross-linking: What do we really know?". Bone (2006) 0.78
Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2014) 0.78
Long-term corticosterone treatment induced lobe-specific pathology in mouse prostate. Prostate (2010) 0.78
Enhanced bone metabolism in vegetarians--the role of vitamin B12 deficiency. Clin Chem Lab Med (2009) 0.78
Inhibition of Protein Farnesylation Arrests Adipogenesis and Affects PPARgamma Expression and Activation in Differentiating Mesenchymal Stem Cells. PPAR Res (2007) 0.78
Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis. Clin Chem Lab Med (2010) 0.78